デフォルト表紙
市場調査レポート
商品コード
1439965

睡眠時無呼吸デバイス - 世界市場の考察、競合情勢、市場予測(2030年)

Sleep Apnea Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030

出版日: 受注後更新 | 発行: DelveInsight | ページ情報: 英文 150 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.89円
睡眠時無呼吸デバイス - 世界市場の考察、競合情勢、市場予測(2030年)
出版日: 受注後更新
発行: DelveInsight
ページ情報: 英文 150 Pages
納期: 2~10営業日
ご注意事項 :
本レポートの納品は、最新情報反映のため受注時に適宜更新しお届けいたします。
更新情報の反映作業にあたり納期もレポート毎に異なりますので、ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の睡眠時無呼吸デバイスの市場規模は、2023年に75億3,000万米ドル、2030年までに108億2,000万米ドルに達し、2024年~2030年の予測期間にCAGRで6.26%の成長が見込まれます。睡眠時無呼吸デバイスの需要は主に、睡眠時無呼吸症例の増加や肥満人口の増加によって押し上げられています。さらに、先進の革新的な技術の採用の増加、睡眠時無呼吸デバイスに関する認知度の向上、老年人口の増加、製品の発売と承認の増加などが、2024年~2030年の予測期間における睡眠時無呼吸デバイス市場全体の成長に寄与しています。

睡眠時無呼吸デバイスの市場力学

睡眠時無呼吸デバイス市場は、さまざまな要因によって製品需要がプラス成長を示しており、主な要因の1つは、糖尿病、喘息、副鼻腔炎などの有病率の増加です。

糖尿病は、呼吸の中枢制御と上気道神経反射に影響を与え、睡眠障害を促進し、慢性閉塞性睡眠障害につながる可能性があり、その結果、人は抑うつ感や不安を感じ、日中の疲労感や眠気につながる可能性があるため、適切な睡眠と抑うつ感や不安のような症状の予防に睡眠デバイスが必要になる可能性があります。さらに、IDF Diabetes Atlas第10版(2022)によると、2022年に世界の成人(20~79歳)の約5億3,700万人が糖尿病患者であり、糖尿病患者の総数は2030年までに6億4,300万人、2045年までに7億8,300万人に増加すると予測されています。同じ資料によると、2022年に120万人以上の子供と青年(0~19歳)が糖尿病患者となっています。したがって、糖尿病人口の増加は、睡眠障害の症例を増加させる可能性があり、これらの患者は、呼吸および上気道神経反射を維持してよりよい睡眠を取るために睡眠時無呼吸デバイスを必要とする可能性があり、それによって睡眠時無呼吸デバイスの全体的な市場成長が推進されます。

Sleep Foundationの2023年4月の発表によると、睡眠不足はいびきや閉塞性睡眠障害につながる可能性があり、人の生活に経済的な影響を与える可能性があります。この経済的影響を抑制するために、人々は夜間に適切な睡眠が必要であり、それによって日中の仕事に適切な注意を払うことができます。このため、人々は夜間に睡眠時無呼吸デバイスを必要とする可能性があります。このように、不眠症の症例の増加は、いびきや閉塞性睡眠障害の増加につながり、最終的に予測年間に睡眠時無呼吸デバイスの需要を増加させます。

睡眠時無呼吸症候群はどの年齢でも発症する可能性がありますが、加齢は睡眠に影響を与える心理社会的要因の有病率の増加と関連しているため、60歳以上の成人はこの疾患を発症するリスクが高いです。したがって、老年人口の増加は、睡眠時無呼吸デバイスの需要を増加させます。例えば、世界保健機関(WHO)(2022)によると、2030年までに世界の6人に1人が60歳以上になると予測されています。この時、60歳以上の人口に占める割合は、世界全体で2020年の10億人から2030年までに14億人に増加します。さらに2050年までに、世界の60歳以上の人口は倍増し、21億人近くになります。同資料の統計によれば、80歳以上の高齢者の数は2020年~2050年に3倍となり、世界で4億2,600万人に達すると予測されています。

さらに、高齢者に睡眠障害が多いのは、体が老化するにつれて筋肉が弱くなり、気道がつぶれて夜間のいびきにつながる可能性があるからです。いびきは、舌、口の天井、喉の筋肉が弛緩することで空気の流れが狭まり、十分な呼吸ができなくなることで起こります。睡眠時無呼吸症候群の治療デバイスは、鼻や口に装着することで、のどを通る空気を増やし、いびきのない睡眠を助けます。したがって、老年人口が増加するにつれて、いびきや睡眠時無呼吸症候群を予防するための睡眠時無呼吸デバイスの必要性が高まります。今後、老年人口の増加が予測期間の睡眠時無呼吸デバイスの需要を増加させる可能性があります。

したがって、上記の要因が2024年~2030年の予測期間における睡眠時無呼吸デバイス市場の成長に寄与しています。

当レポートでは、世界の睡眠時無呼吸デバイス市場について調査分析し、市場規模と予測、促進要因と課題、企業と製品のプロファイルなどを提供しています。

目次

第1章 睡眠時無呼吸デバイス市場レポートのイントロダクション

第2章 睡眠時無呼吸デバイス市場のエグゼクティブサマリー

  • 調査範囲
  • 市場の概要
  • 競合の評価

第3章 規制分析

  • 米国
  • 欧州
  • 日本
  • 中国

第4章 睡眠時無呼吸デバイス市場の主な要因の分析

  • 睡眠時無呼吸デバイス市場の促進要因
  • 睡眠時無呼吸デバイス市場の抑制要因と課題
  • 睡眠時無呼吸デバイス市場の機会

第5章 睡眠時無呼吸デバイス市場のポーターのファイブフォース分析

第6章 睡眠時無呼吸デバイス市場に対するCOVID-19の影響分析

第7章 睡眠時無呼吸デバイス市場情勢

  • 製品タイプ別
    • 治療デバイス
    • 診断デバイス
  • 携帯性別
    • 携帯式
    • 非携帯式
  • エンドユーザー別
    • 病院・診療所
    • 在宅医療
    • その他
  • 地域
    • 北米の睡眠時無呼吸デバイスの市場規模(2021年~2030年)
    • 欧州の睡眠時無呼吸デバイスの市場規模(2021年~2030年)
    • アジア太平洋の睡眠時無呼吸デバイスの市場規模(2021年~2030年)
    • その他の地域の睡眠時無呼吸デバイスの市場規模(2021年~2030年)

第8章 睡眠時無呼吸デバイス市場の企業と製品のプロファイル

  • Koninklijke Philips N.V.
  • ResMed
  • Fisher & Paykel Healthcare Limited.
  • AMBULANC (SHENZHEN) TECH. CO. LTD
  • Beijing Aeonmed Co., Ltd.
  • BMC.
  • BPL Medical Technologies
  • Elmaslar Medikal A.S.
  • Hebei Topson Medical Technology Co., Ltd.
  • Hunan VentMed Medical Technology Co., Ltd
  • Vivos Therapeutics, Inc
  • Guangdong Pigeon Medical Apparatus Co., Ltd.
  • Nihon Kohden Corporation
  • Drive DeVilbiss International
  • Natus Medical Incorporated
  • SOMNOmedics Gmb
  • VYAIRE
  • Compumedics Limited
  • Nox Medical
  • eXciteOSA Inc.

第9章 KOLの見解

第10章 プロジェクトのアプローチ

第11章 DelveInsightについて

第12章 免責事項とお問い合わせ

図表

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: COVID-19 Impact Analysis
  • Table 3: Sleep Apnea Devices Market in Global (2021-2030)
  • Table 4: Sleep Apnea Devices Market in Global by Product Type (2021-2030)
  • Table 5: Sleep Apnea Devices Market in Global by Portability (2021-2030)
  • Table 6: Sleep Apnea Devices Market in Global by End-User (2021-2030)
  • Table 7: Sleep Apnea Devices Market in Global by Geography (2021-2030)
  • Table 8: Sleep Apnea Devices Market in North America (2021-2030)
  • Table 9: Sleep Apnea Devices Market in North America by Country (2021-2030)
  • Table 10: Sleep Apnea Devices Market in the US (2021-2030)
  • Table 11: Sleep Apnea Devices Market in Canada (2021-2030)
  • Table 12: Sleep Apnea Devices Market in Mexico (2021-2030)
  • Table 13: Sleep Apnea Devices Market in Europe (2021-2030)
  • Table 14: Sleep Apnea Devices Market in Europe by Country (2021-2030)
  • Table 15: Sleep Apnea Devices Market in France (2021-2030)
  • Table 16: Sleep Apnea Devices Market in Germany (2021-2030)
  • Table 17: Sleep Apnea Devices Market in the United Kingdom (2021-2030)
  • Table 18: Sleep Apnea Devices Market in Italy (2021-2030)
  • Table 19: Sleep Apnea Devices Market in Spain (2021-2030)
  • Table 20: Sleep Apnea Devices Market in the Rest of Europe (2021-2030)
  • Table 21: Sleep Apnea Devices Market in Asia-Pacific (2021-2030)
  • Table 22: Sleep Apnea Devices Market in Asia-Pacific by Country (2021-2030)
  • Table 23: Sleep Apnea Devices Market in China (2021-2030)
  • Table 24: Sleep Apnea Devices Market in Japan (2021-2030)
  • Table 25: Sleep Apnea Devices Market in India (2021-2030)
  • Table 26: Sleep Apnea Devices Market in Australia (2021-2030)
  • Table 27: Sleep Apnea Devices Market in South Korea (2021-2030)
  • Table 28: Sleep Apnea Devices Market in Rest of Asia-Pacific (2021-2030)
  • Table 29: Sleep Apnea Devices Market in the Rest of the World (2021-2030)
  • Table 30: Sleep Apnea Devices Market in RoW by Region (2021-2030)
  • Table 31: Sleep Apnea Devices Market in the Middle East (2021-2030)
  • Table 32: Sleep Apnea Devices Market in Africa (2021-2030)
  • Table 33: Sleep Apnea Devices Market in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: COVID-19 Impact Analysis
  • Figure 3: Sleep Apnea Devices Market in Global (2021-2030)
  • Figure 4: Sleep Apnea Devices Market in Global by Product Type (2021-2030)
  • Figure 5: Sleep Apnea Devices Market in Global by Portability (2021-2030)
  • Figure 6: Sleep Apnea Devices Market in Global by End-User (2021-2030)
  • Figure 7: Sleep Apnea Devices Market in Global by Geography (2021-2030)
  • Figure 8: Sleep Apnea Devices Market in North America (2021-2030)
  • Figure 9: Sleep Apnea Devices Market in North America by Country (2021-2030)
  • Figure 10: Sleep Apnea Devices Market in the US (2021-2030)
  • Figure 11: Sleep Apnea Devices Market in Canada (2021-2030)
  • Figure 12: Sleep Apnea Devices Market in Mexico (2021-2030)
  • Figure 13: Sleep Apnea Devices Market in Europe (2021-2030)
  • Figure 14: Sleep Apnea Devices Market in Europe by Country (2021-2030)
  • Figure 15: Sleep Apnea Devices Market in France (2021-2030)
  • Figure 16: Sleep Apnea Devices Market in Germany (2021-2030)
  • Figure 17: Sleep Apnea Devices Market in the United Kingdom (2021-2030)
  • Figure 18: Sleep Apnea Devices Market in Italy (2021-2030)
  • Figure 19: Sleep Apnea Devices Market in Spain (2021-2030)
  • Figure 20: Sleep Apnea Devices Market in the Rest of Europe (2021-2030)
  • Figure 21: Sleep Apnea Devices Market in Asia-Pacific (2021-2030)
  • Figure 22: Sleep Apnea Devices Market in Asia-Pacific by Country (2021-2030)
  • Figure 23: Sleep Apnea Devices Market in China (2021-2030)
  • Figure 24: Sleep Apnea Devices Market in Japan (2021-2030)
  • Figure 25: Sleep Apnea Devices Market in India (2021-2030)
  • Figure 26: Sleep Apnea Devices Market in Australia (2021-2030)
  • Figure 27: Sleep Apnea Devices Market in South Korea (2021-2030)
  • Figure 28: Sleep Apnea Devices Market in Rest of Asia-Pacific (2021-2030)
  • Figure 29: Sleep Apnea Devices Market in the Rest of the World (2021-2030)
  • Figure 30: Sleep Apnea Devices Market in RoW by Region (2021-2030)
  • Figure 31: Sleep Apnea Devices Market in the Middle East (2021-2030)
  • Figure 32: Sleep Apnea Devices Market in Africa (2021-2030)
  • Figure 33: Sleep Apnea Devices Market in South America (2021-2030)
  • Figure 34: Market Drivers
  • Figure 35: Market Barriers
  • Figure 36: Marker Opportunities
  • Figure 37: PORTER'S Five Force Analysis
目次
Product Code: DIMDCL0646

Sleep Apnea Devices Market By Product Type (Therapeutic Device [Positive Airway Pressure (PAP), Oral Appliances, Oxygen Devices, And Others] And Diagnostic Device [Pulse Oximeter, Polysomnography Devices (PSG), And Actigraphy Devices]), By Portability (Portable And Non Portable), By End-User (Hospital & Clinics, Home Healthcare, And Others), and by geography expected to grow at a steady CAGR forecast till 2030 owing to the increasing prevalence of sleep apnea and the rising geriatric population base across the globe

The global sleep apnea devices market was valued at USD 7.53 billion in 2023, growing at a CAGR of 6.26% during the forecast period from 2024 to 2030 to reach USD 10.82 billion by 2030. The demand for sleep apnea devices is primarily being boosted due to the increasing cases of sleep apnea, and the rising population with obesity. Further, the rising adoption of advanced and innovative technologies, the rising awareness about sleep apnea devices, the increasing geriatric population, and the increasing product launches and approval among others, thereby contribute to the overall growth of the sleep apnea devices market during the forecast period from 2024-2030.

Sleep Apnea Devices Market Dynamics:

The sleep apnea devices market is witnessing a positive growth in product demand owing to various factors, one of the key factors is the increase in the prevalence of diabetes, asthma, sinusitis, and others.

Diabetes can affect the central control of respiration and upper airway neural reflexes, promoting sleep-disordered and leading to chronic obstructive sleeping disorder which can make a person feel depressed or anxious and can lead to daytime tiredness or sleepiness, thus may need a sleeping device for proper sleep and for preventing depression or anxiety-like symptoms. Further, according to IDF Diabetes Atlas Tenth Edition 2022, in 2022 approximately 537 million adults worldwide (20-79 years) were living with diabetes, and the total number of people living with diabetes is projected to rise to 643 million by 2030 and 783 million by 2045. From the same source, more than 1.2 million children and adolescents (0-19 years) were living with diabetes, in 2022. Thus, the increasing population with diabetes may increase the number of sleep disturbances cases and these patients might need sleep apnea devices to maintain respiration & upper airway neural reflexes to get better sleep, thereby propelling the overall market growth of sleep apnea devices.

According to the sleep foundation April 2023, insufficient sleep may lead to snoring or obstructive sleep disorder and can create an economic impact on a person's life. To control this economic impact people need proper sleep at night so they can give proper attention to their work during the day. For this, people may need sleep apnea devices at the night. Thus, the increasing cases of insomnia will lead to an increased number of snoring or obstructive sleep disorder, ultimately increasing the demand for sleep apnea devices during the forecast year.

Sleep apnea can occur at any age, but adults older than 60 years are at a higher risk of developing this disease as aging is associated with the increasing prevalence of psychosocial factors which affect sleep. Thus, the increasing geriatric population will increase the demand for sleep apnea devices. For instance, as per World Health Organization (WHO) 2022, it is predicted that by 2030, one in six people in the world will be aged 60 years or over. At this time the share of the population aged 60 years and over will increase from 1 billion in 2020 to 1.4 billion in 2030, worldwide. Moreover, by 2050, the world's population of people aged 60 years and older will double which is nearly 2.1 billion. The statistics provided by the same source stated that the number of persons aged 80 years or older is expected to triple between 2020 and 2050 to reach 426 million, globally.

Further, sleep disturbance is more common in older adults because as the body ages the muscles get weakened and may lead to a collapsible airway, leading to nighttime snoring. Snoring happens when the muscles in the tongue, the roof of a person's mouth, and the throat relax which constricts airflow, and a person can't get a full breath. Sleep apnea devices are either attached to the nose or mouth to increase the amount of air that can pass through the throat and help in sleep without snoring. Thus, the increasing geriatric population will increase the need for sleep apnea devices to prevent snoring and sleep apnea. Henceforth, the increasing geriatric population may increase the demand for sleep apnea devices during the forecast period.

Therefore, the above-mentioned factors are contributing to the growth of the sleep apnea devices market during the forecast period from 2024-2030.

However, the high cost of positive airway pressure (PAP) devices, complications due to implantable devices, and others may restrict the sleep apnea devices market growth.

The sleep apnea device market was slightly significantly impacted during the period of COVID- 19 pandemic. The outbreak of the pandemic led to the cancellation of outpatient visits for treatment and surgical procedures. Further, the treatment of patients suffering from chronic diseases such as asthma, diabetes, cardiovascular disorders, sleeping disorder, and others was not a priority as compared to the covid-19 infection. Additionally, the restrictions in the supply chain, raw materials, and other resources halted the manufacture. However, the demand increased significantly with the availability of sleep apnea devices over e-commerce platforms. This led to an increase in the manufacturing of sleep apnea devices. Also, the sleep apnea device provided treatment to patients in a homecare setting, thereby avoiding frequent visits to healthcare professionals. Henceforth, the afore-said factors propelled the demand for sleep apnea devices during the pandemic and are estimated to grow similarly during the forecast period.

Sleep Apnea Devices Market Segment Analysis:

Sleep Apnea Devices Market by Product Type (Therapeutic Device [Positive Airway Pressure (PAP), Oral Appliances, Oxygen Devices, and Others], Diagnostic Device [Pulse Oximeter, Polysomnography Devices (PSG), and Actigraphy Devices]), Portability (Portable and Non-Portable), End-User (Hospital & Clinics, Home Healthcare, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product type segment of the sleep apnea devices market, the positive airway pressure (PAP) device category is expected to amass significant revenue share in the year 2023.

The PAP devices improve sleep quality, lower the risk of heart attack and stroke, and reduces daytime sleepiness. The device eliminates snoring and prevents sleep apnea.

The advantages of the PAP devices over other devices include less discomfort, being non-invasive, and being portable. PAP devices are likely to be the best treatment option in the management of obstructive sleep apnea.

The rising product launches and approvals will create a positive impact on the demand for PAP devices. For instance, in 2022, ResMed launched a new therapeutic air sense 11 PAP (positive airway pressure) device for sleep apnea which provides continuous air pressure to keep the upper airway open and make breathing easy. Many such developments are taking place that includes product launches and approvals, and collaborations, that can boost the segment demand in the upcoming years.

Therefore, the advantages and applications offered by PAP devices are predicted to contribute to the increasing demand for this product type thereby driving the growth of the overall sleep apnea devices market during the forecast period.

North America is expected to dominate the overall Sleep Apnea Devices Market:

Among all the regions, North America is estimated to account for the largest share of the sleep apnea devices market in the year 2023. Owing to the significance of key growth factors such as the rising prevalence of sleep apnea and insomnia, the rising geriatric population base in the region, and the rising chronic nasal congestion, are driving the North American sleep apnea devices market and are expected to witness positive growth in the forecast period. Furthermore, high disposable income, sophisticated healthcare infrastructure, regulatory approval for new devices, and high awareness about sleep apnea devices will also help the market growth in this region.

As per the Centers for Disease and Prevention Control (CDC) 2022, in 2020, 14.5% of adults had trouble falling asleep most days or every day in the past 30 days in the US. A greater percentage of non-Hispanic White (21.0%) adults had trouble staying asleep most days or every day compared with non-Hispanic Black (15.4%), Hispanic (10.6%), and non-Hispanic Asian (8.7%) adults. Younger adults were less likely to have trouble staying asleep (13.8% of those aged 18-44) compared with adults aged 45-64 (21.8%). Thus, people who suffer from any sleep problem due to some other disease can lead to insomnia ultimately they may also feel depression, anxiety, daytime tiredness or sleepiness, and other symptoms which may further lead to breathing disorders and snoring while sleeping. Snoring occurs when pharyngeal muscle tone is lowered during sleep, further reducing the cross-sectional area of the pharynx and leading to increased upper airway resistance. Snoring is often associated with a sleep disorder called obstructive sleep apnea (OSA). Thus, to control this condition of snoring person need a sleep apnea device people may need sleep apnea devices, ultimately increasing the demand for sleep apnea devices and thereby propelling the overall market in the North America region.

According to the CDC 2023, in 2022, 8.0% of people in the US aged 18 and over had asthma. As per the same source, the annual number of hospital visits for asthma was 4.9 million, in 2022, in the US. Asthma causes inflammation and narrowing of the airways, which can trigger irritation and constriction of the small airways which can lead to sleep deprivation. Thus, to maintain these cases of sleep deprivation due to asthma sleep apnea devices can be used. These devices involve wearing a nasal or face mask attached to a machine that delivers continuous air pressure to keep the upper airway open and make breathing easy. Thus, by wearing this device asthma patients can take proper sleep and prevent themselves from sleep deprivation. Hence, increasing cases of asthma will lead to an increase in the demand for sleep apnea devices.

Thus, the aforementioned factors will increase the demand for sleep apnea devices, thereby driving the North American sleep apnea devices market forward during the forecast period.

Sleep Apnea Devices Market Key Players:

Some of the key market players operating in the sleep apnea devices market include Koninklijke Philips N.V., ResMed, Fisher & Paykel Healthcare Limited, and AMBULANCE (SHENZHEN) TECH. CO. LTD, BMC, Beijing Aeonmed Co., Ltd., Hebei Topson Medical Technology Co., Ltd., Hunan VentMed Medical Technology Co., Ltd, Vivos Therapeutics, Inc, Guangdong Pigeon Medical Apparatus Co., Ltd., Nihon Kohden Corporation, Natus Medical Incorporated, SOMNOmedics Gmb, VYAIRE, Compumedics Limited, Drive DeVilbiss International, Nox Medical, eXciteOSA Inc., and others.

Recent Developmental Activities in the Sleep Apnea Devices Market:

In October 2022, Airway Management, announced the launch of flexTAP, a premium lab-made oral appliance, which is designed to treat patients with snoring and mild to moderate obstructive sleep apnea.

In August 2022, Vivos Therapeutics, Inc, received FDA approval for intraoral devices used for snoring and obstructive sleep apnea.

In March 2020, the FDA approved, eXciteOSA by signifier medical technologies, a neuromuscular tongue muscle stimulator for the reduction of snoring and obstructive sleep apnea.

Key Takeaways from the Sleep Apnea Devices Market Report Study

Market size analysis for current sleep apnea devices market size (2023), and market forecast for 5 years (2024-2030)

The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the sleep apnea devices market.

Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years

Key companies dominating the global sleep apnea devices market.

Various opportunities are available for the other competitor in the sleep apnea devices market space.

What are the top-performing segments in 2023? How these segments will perform in 2030.

Which are the top-performing regions and countries in the current sleep apnea devices market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for sleep apnea devices market growth in the coming future?

Target Audience who can be benefited from this Sleep Apnea Devices Market Report Study

Sleep apnea devices products providers

Research organizations and consulting companies

Sleep apnea devices-related organizations, associations, forums, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders dealing in sleep apnea devices

Various End-users who want to know more about the sleep apnea devices market and the latest technological developments in the sleep apnea devices market

Frequently Asked Questions for the Sleep Apnea Devices Market:

1. What is a sleep apnea device?

Sleep apnea device is one of the most common therapies for obstructive sleep apnea. It keeps airways open while sleeping so a person can receive oxygen properly. Sleep apnea devices can significantly improve sleep quality and reduce the risk of several health issues.

2. What is the market for global sleep apnea devices?

The global sleep apnea devices market was valued at USD 7.53 billion in 2023, growing at a CAGR of 6.26% during the forecast period from 2024 to 2030 to reach USD 10.82 billion by 2030.

3. What are the drivers for the global sleep apnea devices market?

The demand for sleep apnea devices is primarily being heightened by the increasing prevalence of obstructive sleep apnea disorders and the increasing chronic diseases which lead to sleep disturbance. In addition, the advancement in sleep apnea devices, the increasing device launches, and approvals among others are thereby contributing to the overall growth of the sleep apnea devices market during the forecast period from 2024-2030.

4. Who are the key players operating in the global sleep apnea devices market?

Some of the key market players operating in the sleep apnea devices market include Koninklijke Philips N.V., ResMed, Fisher & Paykel Healthcare Limited, and AMBULANCE (SHENZHEN) TECH. CO. LTD, BMC, Beijing Aeonmed Co., Ltd., Hebei Topson Medical Technology Co., Ltd., Hunan VentMed Medical Technology Co., Ltd, Vivos Therapeutics, Inc, Guangdong Pigeon Medical Apparatus Co., Ltd., Nihon Kohden Corporation, Natus Medical Incorporated, SOMNOmedics Gmb, VYAIRE, Compumedics Limited, Drive DeVilbiss International, Nox Medical, eXciteOSA Inc., and others.

5. Which region has the highest share in the sleep apnea devices market?

North America is expected to dominate the overall sleep apnea devices market during the forecast period from 2024-2030. Factors such as the rising geriatric population, the rising cases of obesity, the increasing cases of insomnia, and others will propel the demand for sleep apnea devices in North America. Furthermore, increasing technological advancement, sophisticated healthcare infrastructure, regulatory approval for new devices, and high awareness about sleep apnea diseases also helped the market growth in this region.

Table of Contents

1. Sleep Apnea Devices Market Report Introduction

2. Sleep Apnea Devices Market Executive Summary

  • 2.1. Scope of the Study
  • 2.2. Market at Glance
  • 2.3. Competitive Assessment

3. Regulatory Analysis

  • 3.1. The United States
  • 3.2. Europe
  • 3.3. Japan
  • 3.4. China

4. Sleep Apnea Devices Market Key Factors Analysis

  • 4.1. Sleep Apnea Devices Market Drivers
    • 4.1.1. Increasing prevalence of obstructive sleep apnea (OSA)
    • 4.1.2. Rising geriatric population, rising number of obesity, hypertension, and other risk factors across the globe
    • 4.1.3. Increasing awareness among people about sleep apnea devices such as nose clips, chin straps, and others
  • 4.2. Sleep Apnea Devices Market Restraints and Challenges
    • 4.2.1. Complications related to implantable sleep apnea devices
    • 4.2.2. High cost of Positive Airway Pressure (PAP) devices
  • 4.3. Sleep Apnea Devices Market Opportunities
    • 4.3.1. Technological advancements in sleep apnea device

5. Sleep Apnea Devices Market Porter's Five Forces Analysis

  • 5.1. Bargaining Power of Suppliers
  • 5.2. Bargaining Power of Consumers
  • 5.3. The threat of New Entrants
  • 5.4. Threat of Substitutes
  • 5.5. Competitive Rivalry

6. COVID-19 Impact Analysis on Sleep Apnea Devices Market

7. Sleep Apnea Devices Market Layout

  • 7.1. By Product Type
    • 7.1.1. Therapeutic Device
      • 7.1.1.1. Positive Airway Pressure (PAP)
      • 7.1.1.2. Oral Appliances
      • 7.1.1.3. Oxygen devices
      • 7.1.1.4. Others
    • 7.1.2. Diagnostic Device
      • 7.1.2.1. Pulse Oximeter
      • 7.1.2.2. Polysomnography Devices (PSG)
      • 7.1.2.3. Actigraphy Devices
  • 7.2. By Portability
    • 7.2.1. Portable
    • 7.2.2. Non Portable
  • 7.3. By End-User
    • 7.3.1. Hospital & Clinics
    • 7.3.2. Home healthcare
    • 7.3.3. Others
  • 7.4. By Geography
    • 7.4.1. North America Sleep Apnea Devices Market Size in USD Million (2021-2030)
      • 7.4.1.1. The United States Sleep Apnea Devices Market Size in USD Million (2021-2030)
      • 7.4.1.2. Canada Sleep Apnea Devices Market Size in USD Million (2021-2030)
      • 7.4.1.3. Mexico Sleep Apnea Devices Market Size in USD Million (2021-2030)
    • 7.4.2. Europe Sleep Apnea Devices Market Size in USD Million (2021-2030)
      • 7.4.2.1. France Sleep Apnea Devices Market Size in USD Million (2021-2030)
      • 7.4.2.2. Germany Sleep Apnea Devices Market Size in USD Million (2021-2030)
      • 7.4.2.3. United Kingdom Sleep Apnea Devices Market Size in USD Million (2021-2030)
      • 7.4.2.4. Italy Sleep Apnea Devices Market Size in USD Million (2021-2030)
      • 7.4.2.5. Spain Sleep Apnea Devices Market Size in USD Million (2021-2030)
      • 7.4.2.6. Rest of Europe Sleep Apnea Devices Market Size in USD Million (2021-2030)
    • 7.4.3. Asia-Pacific Sleep Apnea Devices Market Size in USD Million (2021-2030)
      • 7.4.3.1. China Sleep Apnea Devices Market Size in USD Million (2021-2030)
      • 7.4.3.2. Japan Sleep Apnea Devices Market Size in USD Million (2021-2030)
      • 7.4.3.3. India Sleep Apnea Devices Market Size in USD Million (2021-2030)
      • 7.4.3.4. Australia Sleep Apnea Devices Market Size in USD Million (2021-2030)
      • 7.4.3.5. South Korea Sleep Apnea Devices Market Size in USD Million (2021-2030)
      • 7.4.3.6. Rest of Asia-Pacific Sleep Apnea Devices Market Size in USD Million (2021-2030)
    • 7.4.4. Rest of the World (RoW) Sleep Apnea Devices Market Size in USD million (2021-2030)
      • 7.4.4.1. Middle East Sleep Apnea Devices Market Size in USD Million (2021-2030)
      • 7.4.4.2. Africa Sleep Apnea Devices Market Size in USD Million (2021-2030)
      • 7.4.4.3. South America Sleep Apnea Devices Market Size in USD Million (2021-2030)

8. Sleep Apnea Devices Market Company and Product Profiles

  • 8.1. Koninklijke Philips N.V.
    • 8.1.1. Company Overview
    • 8.1.2. Company Snapshot
    • 8.1.3. Financial Overview
    • 8.1.4. Product Listing
    • 8.1.5. Entropy
  • 8.2. ResMed
    • 8.2.1. Company Overview
    • 8.2.2. Company Snapshot
    • 8.2.3. Financial Overview
    • 8.2.4. Product Listing
    • 8.2.5. Entropy
  • 8.3. Fisher & Paykel Healthcare Limited.
    • 8.3.1. Company Overview
    • 8.3.2. Company Snapshot
    • 8.3.3. Financial Overview
    • 8.3.4. Product Listing
    • 8.3.5. Entropy
  • 8.4. AMBULANC (SHENZHEN) TECH. CO. LTD
    • 8.4.1. Company Overview
    • 8.4.2. Company Snapshot
    • 8.4.3. Financial Overview
    • 8.4.4. Product Listing
    • 8.4.5. Entropy
  • 8.5. Beijing Aeonmed Co., Ltd.
    • 8.5.1. Company Overview
    • 8.5.2. Company Snapshot
    • 8.5.3. Financial Overview
    • 8.5.4. Product Listing
    • 8.5.5. Entropy
  • 8.6. BMC.
    • 8.6.1. Company Overview
    • 8.6.2. Company Snapshot
    • 8.6.3. Financial Overview
    • 8.6.4. Product Listing
    • 8.6.5. Entropy
  • 8.7. BPL Medical Technologies
    • 8.7.1. Company Overview
    • 8.7.2. Company Snapshot
    • 8.7.3. Financial Overview
    • 8.7.4. Product Listing
    • 8.7.5. Entropy
  • 8.8. Elmaslar Medikal A.S.
    • 8.8.1. Company Overview
    • 8.8.2. Company Snapshot
    • 8.8.3. Financial Overview
    • 8.8.4. Product Listing
    • 8.8.5. Entropy
  • 8.9. Hebei Topson Medical Technology Co., Ltd.
    • 8.9.1. Company Overview
    • 8.9.2. Company Snapshot
    • 8.9.3. Financial Overview
    • 8.9.4. Product Listing
    • 8.9.5. Entropy
  • 8.10. Hunan VentMed Medical Technology Co., Ltd
    • 8.10.1. Company Overview
    • 8.10.2. Company Snapshot
    • 8.10.3. Financial Overview
    • 8.10.4. Product Listing
    • 8.10.5. Entropy
  • 8.11. Vivos Therapeutics, Inc
    • 8.11.1. Company Overview
    • 8.11.2. Company Snapshot
    • 8.11.3. Financial Overview
    • 8.11.4. Product Listing
    • 8.11.5. Entropy
  • 8.12. Guangdong Pigeon Medical Apparatus Co., Ltd.
    • 8.12.1. Company Overview
    • 8.12.2. Company Snapshot
    • 8.12.3. Financial Overview
    • 8.12.4. Product Listing
    • 8.12.5. Entropy
  • 8.13. Nihon Kohden Corporation
    • 8.13.1. Company Overview
    • 8.13.2. Company Snapshot
    • 8.13.3. Financial Overview
    • 8.13.4. Product Listing
    • 8.13.5. Entropy
  • 8.14. Drive DeVilbiss International
    • 8.14.1. Company Overview
    • 8.14.2. Company Snapshot
    • 8.14.3. Financial Overview
    • 8.14.4. Product Listing
    • 8.14.5. Entropy
  • 8.15. Natus Medical Incorporated
    • 8.15.1. Company Overview
    • 8.15.2. Company Snapshot
    • 8.15.3. Financial Overview
    • 8.15.4. Product Listing
    • 8.15.5. Entropy
  • 8.16. SOMNOmedics Gmb
    • 8.16.1. Company Overview
    • 8.16.2. Company Snapshot
    • 8.16.3. Financial Overview
    • 8.16.4. Product Listing
    • 8.16.5. Entropy
  • 8.17. VYAIRE
    • 8.17.1. Company Overview
    • 8.17.2. Company Snapshot
    • 8.17.3. Financial Overview
    • 8.17.4. Product Listing
    • 8.17.5. Entropy
  • 8.18. Compumedics Limited
    • 8.18.1. Company Overview
    • 8.18.2. Company Snapshot
    • 8.18.3. Financial Overview
    • 8.18.4. Product Listing
    • 8.18.5. Entropy
  • 8.19. Nox Medical
    • 8.19.1. Company Overview
    • 8.19.2. Company Snapshot
    • 8.19.3. Financial Overview
    • 8.19.4. Product Listing
    • 8.19.5. Entropy
  • 8.20. eXciteOSA Inc.
    • 8.20.1. Company Overview
    • 8.20.2. Company Snapshot
    • 8.20.3. Financial Overview
    • 8.20.4. Product Listing
    • 8.20.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us